Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

Publication/Presentation Date

4-1-2012

Abstract

This study compares outcomes of low-intensity versus standard-intensity induction strategies for older patients with acute myeloid leukemia at the Weill Cornell Leukemia Program. From 1999 to 2009, 298 adults ≥ 60 years with AML underwent induction chemotherapy with low-intensity and standard-intensity regimens, based on physician and patient preferences and investigational protocol availability. Overall, 33% of the cohort achieved complete remission with initial treatment, 23% with low-intensity induction and 53% with standard-intensity induction (P

Volume

36

Issue

4

First Page

407

Last Page

412

ISSN

1873-5835

Disciplines

Medicine and Health Sciences

PubMedID

22325245

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS